tiprankstipranks
Cardiol Therapeutics (CRDL)
NASDAQ:CRDL
US Market

Cardiol Therapeutics (CRDL) Income Statement

Compare
355 Followers

Cardiol Therapeutics Income Statement

Last quarter (Q3 2024), Cardiol Therapeutics's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, Cardiol Therapeutics's net income was C$-12.73M. See Cardiol Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
C$ 0.00C$ 0.00C$ 78.76KC$ 0.00C$ 0.00
Gross Profit
C$ -248.35KC$ -219.91KC$ 78.76KC$ -229.54KC$ -150.57K
Operating Expenses
C$ 29.54MC$ 41.34MC$ 38.74MC$ 20.69MC$ 14.13M
Depreciation and Amortization
C$ 248.35KC$ 219.91KC$ 220.42KC$ 229.54KC$ 150.57K
EBITDA
C$ -27.88MC$ -30.71MC$ -38.44MC$ -20.41MC$ -13.53M
Operating Income
C$ -29.79MC$ -50.34MC$ -45.47MC$ -20.61MC$ -13.58M
Other Income/Expenses
C$ 1.66MC$ 10.41MC$ 7.03MC$ 49.53KC$ 443.75K
Pretax Income
C$ -28.13MC$ -30.93MC$ -31.64MC$ -20.64MC$ -13.68M
Net Income
C$ -28.13MC$ -11.52MC$ -24.72MC$ -20.65MC$ -13.98M
Per Share Metrics
C$ ―C$ ―C$ ―C$ ―C$ ―
Basic EPS
C$ -0.44C$ -0.18C$ -0.57C$ -0.69C$ -0.54
Diluted EPS
C$ -0.44C$ -0.18C$ -0.57C$ -0.69C$ -0.54
Weighted Average Shares Outstanding
64.46M 62.51M 43.22M 29.86M 25.82M
Weighted Average Shares Outstanding (Diluted)
64.46M 62.51M 43.22M 29.86M 25.82M
Currency in CAD

Cardiol Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis